Polyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder

International Journal of Neuropsychopharmacology

Volumn 17, Issue 3, 2014, Pages 383-391

  Sublette, M Elizabeth ^a,b   Galfalvy, Hanga C ^a,b   Hibbeln, Joseph R ^c   Keilp, John G ^a,b   Malone, Kevin M ^d   Oquendo, Maria A ^a,b   Mann, J John ^a,b  

^a Department of Psychiatry Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Dopamine; Major depressive disorder; Omega 3; Polyunsaturated fatty acids; Prolactin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOPAMINE; FENFLURAMINE; FISH OIL; HOMOVANILLIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROLACTIN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPAMINERGIC ACTIVITY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; SEX DIFFERENCE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FATTY ACIDS, UNSATURATED; FEMALE; FENFLURAMINE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84897091249     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713001399     Document Type: Article

References (79)

1. Ahmad SO, Park JH, Radel JD, Levant B (2008) Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study. Neurosci Lett 438:303-307.
2. Alessandri JM, Extier A, Al-Gubory KH, Harbeby E, Lallemand MS, Linard A, Lavialle M, Guesnet P (2012) Influence of gender on DHA synthesis: the response of rat liver to low dietary alpha-linolenic acid evidences higher omega3 4-desaturation index in females. Eur J Nutr 51:199-209.
3. Appleton KM, Rogers PJ, Ness AR (2010) Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 91:757-770.
4. Arbogast LA, Voogt JL (1991) Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta. Endocrinology 128:997-1005.
5. Balcioglu A, Wurtman RJ (1998) Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: in vivo microdialysis study in conscious animals. Brain Res 813:67-72.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
7. Ben-Jonathan N, Hnasko R (2001) Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724-763.
8. Bezard J, Blond JP, Bernard A, Clouet P (1994) The metabolism and availability of essential fatty acids in animal and human tissues. Reprod Nutr Dev 34:539-568.
9. Bloch MH, Hannestad J (2012a) Response to critiques on 'Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry 17:1163-1167.
10. Bloch MH, Hannestad J (2012b) Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry 17:1272-1282.
11. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979) Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1:131-139.
12. Carboni E, Tanda GL, Frau R, Di Chiara G (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1070.
13. Chalon S, Delion-Vancassel S, Belzung C, Guilloteau D, Leguisquet AM, Besnard JC, Durand G (1998) Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J Nutr 128:2512-2519.
14. Colangelo LA, He K, Whooley MA, Daviglus ML, Liu K (2009) Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition 25:1011-1019.
15. de la Presa Owens S, Innis SM (1999) Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. J Nutr 129:2088-2093.
16. Devoto P, Flore G, Pira L, Longu G, Gessa GL (2004) Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 487:105-111.
17. De Vriese S (2003) Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 73:3181-3187.
18. Dunlop BW, Nemeroff CB (2007) The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64:327-337.
19. Edwards R, Peet M, Shay J, Horrobin D (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48:149-155.
20. First M, Williams J, Spitzer R, Gibbon M (1997) Structured clinical interview for DSM-IV axis I disorders. Washington, DC: American Psychiatric Publishing, Inc.
21. Fitzgerald P, Dinan TG (2008) Prolactin and dopamine: what is the connection? A review article. J Psychopharmacol 22:12-19.
22. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509.
23. Frasure-Smith N (2004) Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 55:891-896.
24. Genedani S, Guidolin D, Leo G, Filaferro M, Torvinen M, Woods AS, Fuxe K, Ferre S, Agnati LF (2005) Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers. J Mol Neurosci 26:177-184.
25. Gertsik L, Poland RE, Bresee C, Rapaport MH (2012) Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol 32:61-64.
26. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP (2005) Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses. J Lipid Res 46:1474-1483.
27. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
28. Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT, Salem N Jr., (1998a) Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry 44:235-242.
29. Hibbeln JR, Umhau JC, Linnoila M, George DT, Ragan PW, Shoaf SE, Vaughan MR, Rawlings R, Salem N Jr., (1998b) A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. Biol Psychiatry 44:243-249.
30. Hodson L, Skeaff CM, Fielding BA (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47:348-380.
31. Hudson AL, Lalies MD, Silverstone P (2012) Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex. Can J Physiol Pharmacol 90:803-809.
32. Jazayeri S, Tehrani-Doost M, Keshavarz S, Hosseini M, Djazayery A, Amini H, Jalali M, Peet M (2008) Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aus &New Zealand J of Psychiatry 42:192-198.
33. Kapur S, Mann JJ (1992) Role of the dopaminergic system in depression. Biol Psychiatry 32:1-17.
34. Keilp JG, Oquendo MA, Stanley BH, Burke AK, Cooper TB, Malone KM, Mann JJ (2010) Future suicide attempt and responses to serotonergic challenge. Neuropsychopharmacol 35:1063-1072.
35. Kim HY, Salem N Jr. (1990) Separation of lipid classes by solid phase extraction. J Lipid Res 31:2285-2289.
36. Kuperstein F, Yakubov E, Dinerman P, Gil S, Eylam R, Salem N Jr., Yavin E (2005) Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n-3 fatty acid dietary deficiency. J Neurochem 95:1550-1562.
37. Kuperstein F, Eilam R, Yavin E (2008) Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n-3 fatty acid dietary deficiency. J Neurochem 106:662-671.
38. Larson MK, Tormoen GW, Weaver LJ, Luepke KJ, Patel IA, Hjelmen CE, Ensz NM, McComas LS, McCarty OJ (2013) Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation. Amer J Physiol Cell Physiol 304:C273-C279.
39. Lee HJ, Rao JS, Ertley RN, Chang L, Rapoport SI, Bazinet RP (2007) Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat. Psychopharmacol (Berl) 190:103-115.
40. Lee HJ, Rao JS, Chang L, Rapoport SI, Kim HW (2010) Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder? Mol Psychiatry 15:602-614.
41. Lin PY, Huang SY, Su KP (2010) A meta-Analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 68:140-147.
42. Lin PY, Mischoulon D, Freeman MP, Matsuoka Y, Hibbeln J, Belmaker RH, Su KP (2012) Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry 17:1161-1163.
43. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H (1996) Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord 38:35-46.
44. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY (1999) Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 85:275-291.
45. Malone KM, Corbitt EM, Li S, Mann JJ (1996) Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 168:324-329.
46. Mamalakis G (2002) Depression and adipose essential polyunsaturated fatty acids. PLEFA 67:311-318.
47. Mann JJ, McBride PA, Brown RP, Linnoila M, Leon AC, DeMeo M, Mieczkowski T, Myers JE, Stanley M (1992) Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 49:442-446.
48. Martins JG (2009) EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 28:525-542.
49. Martins JG, Bentsen H, Puri BK (2012) Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. Mol Psychiatry 17:1144-1149.
50. Masana M, Bortolozzi A, Artigas F (2011) Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia. Int J Neuropsychopharmacol 14:53-68.
51. Masana M, Castane A, Santana N, Bortolozzi A, Artigas F (2012) Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies. Neuropharmacol 63:675-684.
52. Morrison WR, Smith LM (1964) Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 53:600-608.
53. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ (2003) Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 60:14-22.
54. Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43:315-319.
55. Perez SE, Berg BM, Moore KA, He B, Counts SE, Fritz JJ, Hu YS, Lazarov O, Lah JJ, Mufson EJ (2010) DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects. J Neurosci Res 88:1026-1040.
56. Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ (2001) Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry 50:783-791.
57. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH (2003) Two formulas for computation of the area under the curve represent measures of total hormone concentration vs. time-dependent change. Psychoneuroendocrinol 28:916-931.
58. Rao JS, Rapoport SI (2009) Mood-stabilizers target the brain arachidonic acid cascade. Current Molecular Pharmacol 2:207-214.
59. Rockett BD, Franklin A, Harris M, Teague H, Rockett A, Shaikh SR (2011) Membrane raft organization is more sensitive to disruption by (n-3) PUFA than nonraft organization in EL4 and B cells. J Nutr 141:1041-1048.
60. Rockett BD, Teague H, Harris M, Melton M, Williams J, Wassall SR, Shaikh SR (2012) Fish oil increases raft size and membrane order of B cells accompanied by differential effects on function. J Lipid Res 53(4):674-685.
61. Ross BM, Seguin J, Sieswerda LE (2007) Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis 6:21.
62. Scheinin M, Chang WH, Kirk KL, Linnoila M (1983) Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with highperformance liquid chromatography using electrochemical detection. Anal Biochem 131:246-253.
63. Sher L (2003) Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls. Psychoneuroendocrinol 28:559-573.
64. Sher L, Mann JJ, Traskman-Bendz L, Winchel R, Huang YY, Fertuck E, Stanley BH (2006) Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters. J Affect Disord 90:83-89.
65. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ (2006) Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 163:1100-1102.
66. Sublette ME, Milak MS, Hibbeln JR, Freed PJ, Oquendo MA, Malone KM, Parsey RV, John Mann J (2009) Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression. PLEFA 80:57-64.
67. Sublette ME, Ellis SP, Geant AL, Mann JJ (2011) Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 72(12):1577-1584.
68. Tanda G, Pontieri FE, Frau R, Di Chiara G (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-2085.
69. Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J, Vartiainen E (2001) Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52:529-531.
70. Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM (2003) Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam study. Am J Clin Nutr 78:40-46.
71. Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Rasanen P (2004) Fish consumption and depression: the Northern Finland 1966 birth cohort study. J Affect Disord 82:447-452.
72. Williams JA, Batten SE, Harris M, Rockett BD, Shaikh SR, Stillwell W, Wassall SR (2012) Docosahexaenoic and eicosapentaenoic acids segregate differently between raft and nonraft domains. Biophys J 103:228-237.
73. Willner P (1983a) Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res 287:211-224.
74. Willner P (1983b) Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments. Brain Res 287:237-246.
75. Willner P (1983c) Dopamine and depression: a review of recent evidence. II. Theoretical approaches. Brain Res 287:225-236.
76. Yu P, Yang Z, Jones JE, Wang Z, Owens SA, Mueller SC, Felder RA, Jose PA (2004) D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int 66:2167-2180.
77. Zimmer L, Hembert S, Durand G, Breton P, Guilloteau D, Besnard JC, Chalon S (1998) Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. Neurosci Lett 240:177-181.
78. Zimmer L, Delpal S, Guilloteau D, Aïoun J, Durand G, Chalon S (2000a) Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci Lett 284:25-28.
79. Zimmer L, Delion-Vancassel S, Durand G, Guilloteau D, Bodard S, Besnard JC, Chalon S (2000b) Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41:32-40.